Emphasis (Completed)
A Comparison Of Outcomes In Patients In New York Heart Association (NYHA) Class II Heart Failure When Treated With Eplerenone Or Placebo In Addition To Standard Heart Failure Medicines (EMPHASIS-HF)
- Medicine
- inspra (eplerenone)
- Population
- Heart failure
- Phase
- III
- Starting year
- 2005
- More information
- ClinicalTrials.gov